D.E. Shaw & Co’s Ault Disruptive Technologies Corporation Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 ADRT.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-262,499
Closed -$10K 5551
2022
Q3
$10K Hold
262,499
﹤0.01% 4951
2022
Q2
$26K Buy
262,499
+175,000
+200% +$18K ﹤0.01% 4968
2022
Q1
$15K Buy
+87,499
New +$15.4K ﹤0.01% 5378

Other funds holding ADRT.WS

D.E. Shaw & Co's ADRT.WS Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Ault Disruptive Technologies Corporation Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 (ADRT.WS) in Q4 2022, closing a stake of 262,499 shares — an estimated $10K sold.

D.E. Shaw & Co first reported a position in ADRT.WS in Q1 2022 and held it in 3 quarters. The position peaked at $26K in Q2 2022. 7 funds tracked by Wall St. Rank hold ADRT.WS as of Q4 2022.

  • D.E. Shaw & Co reported no remaining Ault Disruptive Technologies Corporation Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 262,499 Ault Disruptive Technologies Corporation Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q4 2022, an estimated $10K.
  • D.E. Shaw & Co first reported a position in Ault Disruptive Technologies Corporation Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 in Q1 2022 and held it in 3 quarters.
  • D.E. Shaw & Co's Ault Disruptive Technologies Corporation Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $26K in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Ault Disruptive Technologies Corporation Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.